Harvey Partners, LLC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Harvey Partners, LLC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$10,997,250
-20.6%
2,557,500
+1.3%
1.39%
-17.8%
Q2 2023$13,856,760
+21.6%
2,524,000
-7.0%
1.70%
+20.2%
Q1 2023$11,393,340
+41.3%
2,712,700
-6.8%
1.41%
+37.6%
Q4 2022$8,064,855
+8.2%
2,911,500
+0.0%
1.02%
-6.0%
Q3 2022$7,453,000
-27.7%
2,911,300
+1.6%
1.09%
-51.9%
Q2 2022$10,314,000
-25.4%
2,865,000
+28.7%
2.27%
-33.5%
Q1 2022$13,823,000
+55.0%
2,226,000
+76.0%
3.41%
-6.0%
Q4 2021$8,918,000
+25.3%
1,265,000
+24.0%
3.62%
-31.9%
Q3 2021$7,120,000
-22.3%
1,020,036
-7.3%
5.32%
-16.1%
Q2 2021$9,163,000
+52.6%
1,100,0000.0%6.34%
+53.1%
Q1 2021$6,006,000
+41.0%
1,100,000
+10.8%
4.14%
+40.1%
Q4 2020$4,260,000
+79.1%
993,000
+25.7%
2.96%
-4.2%
Q3 2020$2,378,000
-7.1%
790,000
-4.3%
3.09%
+0.1%
Q2 2020$2,559,000
-32.2%
825,500
-51.7%
3.09%
-9.7%
Q1 2020$3,776,000
+22.4%
1,708,466
+68.9%
3.42%
+94.8%
Q4 2019$3,086,000
+35.2%
1,011,701
+36.3%
1.75%
+6.3%
Q3 2019$2,283,000742,5001.65%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Harvey Partners, LLC 1,020,036$7,120,0005.32%
Portolan Capital Management 2,358,010$16,459,0001.20%
Acuitas Investments, LLC 375,836$2,623,0001.14%
Parkman Healthcare Partners LLC 475,367$3,318,0000.84%
Adirondack Research & Management Inc. 90,020$628,0000.76%
Archon Capital Management LLC 736,236$5,139,0000.73%
BARD ASSOCIATES INC 294,697$2,057,0000.70%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 1,621,775$11,320,0000.65%
GLOBEFLEX CAPITAL L P 268,466$1,874,0000.41%
Monarch Partners Asset Management LLC 330,083$2,304,0000.34%
View complete list of HARVARD BIOSCIENCE INC shareholders